HLA-B
Overview
HLA-B encodes an MHC class I heavy chain that presents peptides to CD8 T cells; loss or mutation of HLA-B contributes to tumor immune escape.
Alterations observed in the corpus
- HLA-B mutations were observed as part of the subset of private mutations unique to NSCLC brain metastases in the MSK BM cohort PMID:37591896.
- MHC class I gene highly expressed in HGSOC Cancer.cell.3 cluster; subject to LOH-mediated loss in 6p as immune escape mechanism PMID:36517593
- MHC class I alteration enriched in MSI gastric adenocarcinoma (STAD) tumours (TCGA); consistent with antigen-presentation escape mechanism; co-altered with B2M PMID:25079317
- Somatic HLA class I (HLA-A/B/C) mutations identified in 11% of colorectal cancer cases; mutations enriched at TCR-binding and peptide-contact residues; consistent with immune-escape selection in TIL-rich tumors PMID:26997480
- Implicated in MHC-I antigen presentation loss alongside B2M deletion in TCGA pan-lung cancer cohort (lung ADC and SqCC) PMID:27158780
Cancer types (linked)
- NSCLC / LUAD — private alterations in brain metastases PMID:37591896.
Co-occurrence and mutual exclusivity
- Not reported in the corpus.
Therapeutic relevance
- Not reported in the corpus.
Open questions
- None flagged in the corpus.
Sources
This page was processed by crosslinker on 2026-05-05. - PMID:36517593
This page was processed by crosslinker on 2026-05-05. - PMID:25079317
This page was processed by wiki-cli on 2026-05-11. - PMID:26997480
This page was processed by wiki-cli on 2026-05-14. - PMID:27158780
This page was processed by wiki-cli on 2026-05-14.